ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.9765
0.19%
Brent Oil
83.63
0.11%
Bitcoin
59,325.49
1.87%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Caribou Biosciences Inc (CRBU)

  7. Caribou Biosciences Inc (CRBU) Noticias

CRBU Caribou Biosciences Inc

3.71
0.02 (0.54%)
Fuera de horario
Última actualización: 16:08:59
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Caribou Biosciences Inc CRBU NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.02 0.54% 3.71 16:08:59
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.75 3.56 3.82 3.64 3.69
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202415:05GLOBECaribou Biosciences to Participate in Upcoming Investor..
24/4/202409:00GLOBECaribou Biosciences to Present Initial Dose Expansion Data..
15/4/202408:00GLOBECaribou Biosciences Announces Oral Presentation on In Vivo..
04/4/202415:00GLOBECaribou Biosciences Expands Clinical Development of CB-010..
11/3/202416:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/3/202415:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202415:22EDGAR2Form 8-K - Current report
11/3/202415:05GLOBECaribou Biosciences Reports Fourth Quarter and Full Year..
05/3/202415:30GLOBECaribou Biosciences to Present Preclinical Data on CB-012,..
22/2/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:05GLOBECaribou Biosciences to Participate in Upcoming Investor..
08/2/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:18EDGAR2Form 3/A - Initial statement of beneficial ownership of..
09/1/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202415:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202415:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/1/202407:00EDGAR2Form 8-K - Current report
07/1/202410:00GLOBECaribou Biosciences Appoints Tim Kelly as Chief Technology..
22/12/202315:05EDGAR2Form 8-K - Current report
13/12/202305:30IHMARKETNEWSCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend..
12/12/202317:26DJNCaribou Biosciences Shares Rise 4.1% as FDA Approves..
12/12/202315:05EDGAR2Form 8-K - Current report
12/12/202315:02GLOBECaribou Biosciences Provides Regulatory Update on CB-010..
17/11/202315:06EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
17/11/202315:05EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
07/11/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:02EDGAR2Form 8-K - Current report
07/11/202315:00GLOBECaribou Biosciences Reports Third Quarter 2023 Financial..
06/11/202307:00GLOBECaribou Biosciences Announces Appointment of Sundar..
01/11/202315:05GLOBECaribou Biosciences to Participate in Upcoming Investor..
18/10/202307:02EDGAR2Form 8-K - Current report
18/10/202307:00GLOBECaribou Biosciences Announces FDA Clearance of IND..
27/9/202307:00GLOBECaribou Biosciences Appoints Reigin Zawadzki as Chief People..
26/9/202315:05EDGAR2Form 8-K - Current report
29/8/202315:00GLOBECaribou Biosciences to Participate in Upcoming Investor..
08/8/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:03EDGAR2Form 8-K - Current report
08/8/202315:00GLOBECaribou Biosciences Reports Second Quarter 2023 Financial..
14/7/202316:31EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/7/202315:22EDGAR2Form 8-K/A - Current report: [Amend]
14/7/202306:51IHMARKETNEWSFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase,..

Su Consulta Reciente

NASDAQ
CRBU
Caribou Biosciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados